Extensive experience in designing photopharmacological small molecules and supramolecular drugs, in silico and in vitro compound screening, and target validation projects related to cancer, infectious diseases, CNS related diseases and … Read more
IBEC has a wide expertise in designing, fabricating and characterizing biomaterials for use in biological and health applications, in particular regenerative therapies. We put emphasis both in the study of … Read more
IBEC has specialized expertise in designing nanoparticle-based therapies encompassing fabrication, characterization, functionalization, behavior modeling, and in vivo/in vitro testing. Focus Areas:
Last week I showed a teaser of my video. Far from being finished, it was meant to share a current state of my work and to get into the mood … Read more
My initial interest was in the historical and fictional exploration of the techniques made possible by working in cell culture lab. The possibility of cultivating living matter outside the body, … Read more
Un estudio liderado por el IBEC e ISGlobal ha demostrado el potencial antileishmanial de un compuesto antimalárico. Diseñado inicialmente para la malaria, este fármaco muestra una elevada eficacia contra la leishmaniosis, marcando un avance único y prometedor para el tratamiento de ambas infecciones.
Delivering effector molecules in cells in vitro and ex vivo by photoporation. Kevin Braeckmans, Biophotonics Research Group, Lab. General Biochemistry and Physical Pharmacy, Ghent University, Belgium Delivery of bioactive compounds, … Read more
Expertos en Nanomedicina de diferentes campos se han reunido hoy por quinto año consecutivo en el Nano Rare Diseases Day. Se trata de un evento coorganizado por la plataforma NANOMED Spain, coordinada por el IBEC, y el Hospital Sant Joan de Déu, donde se exponen los últimos avances en nanomedicina para el diagnóstico y el tratamiento de las enfermedades minoritarias.
